Alpha Family Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Alpha Family Trust’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$402K	Sell	645 -55	-8%	-$37.4K	0.16%	99
2026 Q1	$541K	Sell	700 -75	-10%	-$57.4K	0.26%	65
2025 Q4	$598K	Buy	775 +105	+16%	+$71.3K	0.27%	67
2025 Q3	$377K	Buy	+670	New	+$379K	0.18%	103
2025 Q2	–	Sell	-595	Closed	-$377K	–	197
2025 Q1	$377K	Hold	595	–	–	0.22%	84
2024 Q4	$424K	Hold	595	–	–	0.24%	66
2024 Q3	$625K	Hold	595	–	–	0.35%	55
2024 Q2	$625K	Hold	595	–	–	0.37%	51
2024 Q1	$573K	Hold	595	–	–	0.35%	55
2023 Q4	$523K	Hold	595	–	–	0.35%	53
2023 Q3	$490K	Sell	595 -25	-4%	-$19.6K	0.37%	54
2023 Q2	$445K	Sell	620 -25	-4%	-$19.3K	0.31%	53
2023 Q1	$530K	Buy	645 +55	+9%	+$41.5K	0.42%	47
2022 Q4	$426K	Buy	+590	New	+$435K	0.38%	49

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Alpha Family Trust's REGN Position: Q2 2026 in Review

Alpha Family Trust reduced its Regeneron Pharmaceuticals (REGN) stake by 7.9% in Q2 2026, selling an estimated $37.4K and leaving 645 shares worth $402K. The position accounts for 0.16% of the portfolio, ranked #99.

Alpha Family Trust first reported a position in REGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $625K in Q3 2024. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Alpha Family Trust held 645 shares of Regeneron Pharmaceuticals worth $402K as of Q2 2026.
Alpha Family Trust sold 55 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $37.4K.
Regeneron Pharmaceuticals made up 0.16% of Alpha Family Trust's portfolio in Q2 2026, its #99 holding.
Alpha Family Trust first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
Alpha Family Trust's Regeneron Pharmaceuticals position peaked at $625K in Q3 2024.
1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Alpha Family Trust's 13F filing for Q2 2026, filed 10 Aug 2026.